Adia Med Inc ADIA
0.06 USD 0.00 (+5.26%)
Nov 4, 2026, 1:55 PM EST
0.061 Day range 0.062
0.023 52-week range 0.278
- YTD
- -20.51%
- 1 year
- +148.00%
- Market cap
- 5.85M
- YTD return
- -20.51%
- 1-year return
- +148.00%
- Volume
- 1.61K
- Avg volume
- 17.57K
- Open
- 0.061
- Previous close
- 0.0589
- Day's range
- 0.061 – 0.062
- 52-week range
- 0.023 – 0.278
2Y +0.0570 (+1140.00%)
News
Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues 
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash 
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position 
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million 
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line 
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products 
Nasdaq Shareholder Requirements Just Verified By Adia Med 
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team 
Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting 
Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half
Your note
Sign in to keep a note on ADIA — it syncs with the Stock Master app.